NaB-induced inhibition of HDAC4 and TUG1: a novel strategy for reversing oxaliplatin resistance in colorectal cancer
- DOI
- 10.1186/s12885-026-16367-7
- Published
- 2026-11-03
- Container
- BMC Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12885-026-16367-7,
title = {NaB-induced inhibition of HDAC4 and TUG1: a novel strategy for reversing oxaliplatin resistance in colorectal cancer},
author = {Wang Yingchen and Wu Yinhang and Zhuang Jing and Chu Jian and Wu Zheng and Liu Jiang and Han Shuwen},
year = {2026},
journal = {BMC Cancer},
doi = {10.1186/s12885-026-16367-7},
url = {https://doi.org/10.1186/s12885-026-16367-7}
}RIS
TY - JOUR TI - NaB-induced inhibition of HDAC4 and TUG1: a novel strategy for reversing oxaliplatin resistance in colorectal cancer AU - Wang Yingchen AU - Wu Yinhang AU - Zhuang Jing AU - Chu Jian AU - Wu Zheng AU - Liu Jiang AU - Han Shuwen PY - 2026 JO - BMC Cancer DO - 10.1186/s12885-026-16367-7 UR - https://doi.org/10.1186/s12885-026-16367-7 ER -
APA
Yingchen, W., Yinhang, W., Jing, Z., Jian, C., Zheng, W., Jiang, L., & Shuwen, H. (2026). NaB-induced inhibition of HDAC4 and TUG1: a novel strategy for reversing oxaliplatin resistance in colorectal cancer. BMC Cancer. https://doi.org/10.1186/s12885-026-16367-7
Source records
- crossref · retrieved 2026-11-04T10:36:40.279Z